Drugs / Fludeoxyglucose (18F)-IBA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01089998 | May 2010 → Sep 2011 | — | Lantheus Biosciences Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fludeoxyglucose (18F)-IBA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01089998 ↗ |